Researchers sought to assess whether retrospective drug feedback increased adherence to HIV pre-exposure prophylaxis among young women in South Africa and Zimbabwe.
Younger individuals, African American and Latinx, those with substance use disorders more likely to discontinue PrEP.
The outcomes of this review will provide relevant information for healthcare professionals, policy makers, and commissioners about how best to evaluate national PrEP programs.
Investigators conducted a retrospective molecular epidemiologic study to assess transmitted drug resistance in patients recently diagnosed with HIV infection.
In a randomized controlled trial, researchers compared emtricitabine and tenofovir alafenamide with tenofovir disoproxil fumarate for reducing the risk of HIV infection in high-risk cisgender men and transgender women who have sex with men.
To facilitate increased use of PrEP, researchers from France developed a machine-learning algorithm to identify individuals at increased risk for HIV infection.
Nearly all health insurers must cover the entire cost of HIV prevention treatments, the US government says.
A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.
The researchers examined trends in PrEP uptake at the state and regional level from 2014 to 2018 and assessed whether early adoption of PrEP had offered long-term gains.
A safety review evaluated several studies assessing the safety of PrEP in pregnant women, including the Partners PrEP Study, TDF2 Study, FEM-PrEP, and VOICE.
